"This is the first positive signal of any degree of vaccine efficacy in humans, more than a quarter-century after scientists discovered the virus that causes AIDS. ... On the other hand, many questions remain about the RV144 trial, and these issues will be addressed in this editorial."
Read more in Retrovirology, October 9, 2009 - open access, full editorial available for download.
0 comments:
Post a Comment